These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11556345)

  • 1. Etanercept AL amyloidosis.
    Drewe E; Powell RJ
    Lancet; 2001 Sep; 358(9283):761. PubMed ID: 11556345
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.
    Zeichner JA; Stern DW; Lebwohl M
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322
    [No Abstract]   [Full Text] [Related]  

  • 3. [Etanercept: enbrel].
    Sparsa A
    Ann Dermatol Venereol; 2007 Dec; 134(12):972-7. PubMed ID: 18166920
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.
    Matejicka C; Morgan GJ; Schlegelmilch JG
    Arthritis Rheum; 2003 Mar; 48(3):864-6. PubMed ID: 12632456
    [No Abstract]   [Full Text] [Related]  

  • 5. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
    Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
    Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
    Thayer S; Watson C; Song R; Globe DR; Harrison DJ
    J Med Econ; 2010; 13(2):228-35. PubMed ID: 20459298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic approach to erythema annulare centrifugum.
    Minni J; Sarro R
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S134-5. PubMed ID: 16488327
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept treatment in corticosteroid-dependent myasthenia gravis.
    Rowin J; Meriggioli MN; Tüzün E; Leurgans S; Christadoss P
    Neurology; 2004 Dec; 63(12):2390-2. PubMed ID: 15623708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
    Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
    Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
    [No Abstract]   [Full Text] [Related]  

  • 11. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.
    Vine K; Votava HJ; Smith BL
    Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
    Gordon K; Korman N; Frankel E; Wang H; Jahreis A; Zitnik R; Chang T
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S101-11. PubMed ID: 16488320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response to anti-TNF-alpha treatment for secondary renal amyloidosis in a patient with ankylosing spondylitis].
    Bellissimo S; Ferrucci MG; Gallo A; Stisi S
    Reumatismo; 2007; 59(3):240-3. PubMed ID: 17898885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease.
    Serratrice J; Granel B; Disdier P; Weiller PJ; Dussol B
    Am J Med; 2003 Nov; 115(7):589-90. PubMed ID: 14599647
    [No Abstract]   [Full Text] [Related]  

  • 15. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L;
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of severe nail psoriasis with etanercept.
    Coelho JD; Diamantino F; Lestre S; Ferreira AM
    Indian J Dermatol Venereol Leprol; 2011; 77(1):72-4. PubMed ID: 21220889
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.